Key considerations for differentiated antiretroviral therapy delivery for specific populations: children, adolescents, pregnant and breastfeeding women and key populations

Simple item page
dc.coverageGeneva
dc.creatorWorld Health Organization
dc.date2017-07-19T11:52:41Z
dc.date2017-07-20T16:00:00Z
dc.date2017-07-19
dc.date.accessioned2026-08-03T14:38:42Z
dc.description66 p.
dc.formatapplication/pdf
dc.identifierWHO/HIV/2017.34
dc.identifierhttps://iris.who.int/handle/10665/258506
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/268625
dc.languageEnglish
dc.languageen
dc.publisherWorld Health Organization
dc.rightsCC BY-NC-SA 3.0 IGO
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/3.0/igo
dc.rightsWorld Health Organization
dc.subjectHIV
dc.subjectHIV Infections
dc.subjectAnti-Retroviral Agents
dc.subjectAnti-HIV Agents
dc.subjectChild
dc.subjectAdolescent
dc.subjectWomen
dc.subjectVulnerable Populations
dc.titleKey considerations for differentiated antiretroviral therapy delivery for specific populations: children, adolescents, pregnant and breastfeeding women and key populations
dc.typeTechnical Documents

Files

Collections

WHO IRIS